Webwinkel Keurmerk en klantbeoordelingen
info

You have reached the minimum number

Shopping cart (0)

There are no products in your shopping cart yet.

ESSENTIAL OIL OF BERGAMOT AS A NOVEL THERAPEUTIC APPROACH

ESSENTIAL OIL OF BERGAMOT AS A NOVEL THERAPEUTIC APPROACH
A very interesting research (2019) on the NEUROPHARMACOLOGY OF THE NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA AND ROLE OF PAIN: ESSENTIAL OIL OF BERGAMOT AS A NOVEL THERAPEUTIC APPROACH

Abstract:

Aging of the population makes of dementia a challenge for health systems worldwide. The cognitive disturbance is a serious but not the only issue in dementia; behavioral and psychological syndromes known as neuropsychiatric symptoms of dementia remarkably reduce the quality of life.

The cluster of symptoms includes anxiety, depression, wandering, delusions, hallucinations, misidentifications, agitation, and aggression. The pathophysiology of these symptoms implicates all the neurotransmitter systems, with a pivotal role for the glutamatergic neurotransmission.

Imbalanced glutamatergic and GABAergic neurotransmissions, over-activation of the extra synaptic N-methyl-D-aspartate (NMDA) receptors and alterations of the latter have been linked to the development of neuropsychiatric symptoms experienced by almost the entire demented population. Drugs with efficacy and safety for prevention or long-term treatment of these disorders are not available yet.

Aromatherapy provides the best evidence for positive outcomes in the control of agitation, the most resistant symptom. Demented patients often cannot verbalize pain, resulting in unrelieved symptoms and contributing to agitation.

Bergamot essential oil provides extensive preclinical evidence of analgesic properties. Incidentally, the essential oil of bergamot induces anxyolitic-like effects devoid of sedation, typical of benzodiazepines, with a noteworthy advantage for demented patients.

These data, together with the reported safety profile, form the rational basis for bergamot as a neurotherapeutic to be trialed for the control of behavioral and psychological symptoms of dementia.


You can read the whole research here: bit.ly/36dH8p3
  j'Olie et Co     18-09-2021 19:43
This website uses cookies to measure visits, no personal data is stored.